Disease Overview：Female infertility（FI）
Female infertility refers to the inability of a woman to conceive after one year of regular, unprotected intercourse—or six months if over age 35. It may result from ovulatory disorders (e.g., PCOS, hypothalamic amenorrhea), tubal factor infertility (often due to pelvic inflammatory disease or endometriosis), uterine abnormalities (such as fibroids or adhesions), diminished ovarian reserve, or unexplained causes. Diagnosis involves comprehensive evaluation: hormonal profiling (FSH, AMH, estradiol), transvaginal ultrasound, hysterosalpingography (HSG), and sometimes laparoscopy or genetic testing. Treatment modalities range from ovulation induction and intrauterine insemination (IUI) to advanced assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and preimplantation genetic testing (PGT).
China offers distinct advantages for international patients seeking infertility care. Leading reproductive medicine centers—many accredited by ISO and affiliated with top-tier academic hospitals—employ board-certified reproductive endocrinologists and embryologists trained internationally. State-of-the-art laboratories feature time-lapse embryo imaging, vitrification systems, and next-generation sequencing for PGT-A/PGT-M. Clinical success rates align with global benchmarks: live birth rates per fresh IVF cycle exceed 45% for women under 35, supported by robust longitudinal outcome data. Crucially, treatment costs are typically 40–60% lower than in the US, UK, or Australia—without compromising clinical rigor or regulatory oversight (NMPA-approved devices, strict ART licensing).
As a dedicated medical tourism agency, we facilitate seamless access to these services: vetting JCI-aligned hospitals, coordinating consultations and treatment timelines, providing transparent, all-inclusive pricing (with no hidden fees), and offering end-to-end support—from visa assistance and accommodation to multilingual patient coordinators and post-treatment follow-up.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Female Infertility (Reproductive Medicine Department)
Non-Surgical / Conservative / Medication-Based Options
*Target criteria:* Ovulatory dysfunction (e.g., PCOS, hypothalamic amenorrhea), mild tubal factor, unexplained infertility, or as first-line therapy for age <35 with normal ovarian reserve and anatomy.
- •Ovulation Induction (Clomiphene Citrate or Letrozole)
- Cycle monitoring (2–3 transvaginal ultrasounds + serum progesterone): $180–$270 - Medication (3-month course): $30–$55 *Total per cycle: $255–$390*
- •Gonadotropin Stimulation (hMG/rFSH)
- Monitoring (4–6 ultrasounds + 4–6 hormone assays): $360–$540 - Medication (10–14 days): $220–$410 *Total per cycle: $655–$1,060*
Surgical / Procedural / Interventional Options
*Eligibility:* Confirmed tubal obstruction, moderate-severe endometriosis (rASRM Stage III–IV), uterine cavity pathology (submucosal fibroids, polyps, adhesions), or failed ovulation induction.
- •Diagnostic Laparoscopy + Hysteroscopy (with therapeutic intervention)
- Procedure (combined lap-hystero, adhesiolysis, cystectomy, tubal cannulation, polypectomy): $1,850–$3,200 - Post-op histopathology (if biopsy taken): $45–$85 *Total: $2,015–$3,465*
- •Tubal Microsurgery (e.g., neosalpingostomy, anastomosis)
- Surgery (microsurgical repair under magnification): $2,900–$4,700 *Total: $2,985–$4,830*
Special / Complex Condition Management
- •IVF-ET (In Vitro Fertilization – Embryo Transfer)
- Ovarian stimulation + egg retrieval + ICSI + embryo culture (Day 3 or blastocyst): $4,100–$6,900 - Frozen embryo transfer (FET) cycle: $1,450–$2,300 *Total per fresh IVF cycle: $4,420–$7,480*
Quick Selection Guide
- •Age <35, budget-constrained, mild ovulatory disorder: Start with Letrozole + monitoring ($255–$390/cycle); 3 cycles before escalation.
- •Age 35–39, normal tubes/AFC, unexplained infertility: Proceed to gonadotropin stimulation ($655–$1,060/cycle) or directly to IVF if >2 years infertility.
- •Age ≥40 or diminished ovarian reserve (AFC <5, AMH <1.0 ng/mL): Bypass ovulation induction; initiate IVF immediately ($4,420–$7,480).
- •Confirmed tubal occlusion or Stage IV endometriosis: Diagnostic laparoscopy + hysteroscopy ($2,015–$3,465) is first-line surgical step; IVF preferred post-op if no natural conception within 6 months.
- •Recurrent pregnancy loss + suspected uterine anomaly: Prioritize hysteroscopy + metroplasty ($1,950–$3,300) before IVF.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Female infertility Medical Vacation Packages
Curated transparent all-inclusive packages combining Female infertility treatment with China top medical destinations:
